Ranolazine is associated with a reduced incidence of atrial fibrillation in patients with chronic coronary syndrome: the results of a real-world analysis of an Italian population

被引：0
|
作者：
Fumagalli, S. [1 ]
Dovizio, M. [2 ]
Mazzoni, S. [2 ]
Montorzi, R. Franci [1 ]
Santamaria, E. [1 ]
Fumagalli, C. [3 ]
Degli Esposti, L. [2 ]
Marchionni, N. [1 ]
机构：
[1] Geriatr Intens Care Unit, Florence, Italy
[2] CliCon Srl, Soc Benefit Hlth Econ & Outcomes Res, Bologna, Italy
[3] Univ Campania Luigi Vanvitelli, Naples, Italy
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Rivaroxaban Precision Dosing Strategy for Real-World Atrial Fibrillation Patients
    Konicki, Robyn
    Weiner, Daniel
    Herbert Patterson, J.
    Gonzalez, Daniel
    Kashuba, Angela
    Cao, Yanguang Carter
    Gehi, Anil K.
    Watkins, Paul
    Powell, J. Robert
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (04): : 777 - 784
  • [32] Incidence of atrial fibrillation detected by an insertable cardiac monitor in a large real-world cohort of heart failure patients with reduced and preserved ejection fraction
    Shahzeb Khan, M.
    Kahwash, R.
    Zile, M. R.
    Sarkar, S.
    Van Dorn, B.
    Gerritse, B.
    Butler, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [33] Real-world performance of the atrial fibrillation monitor in patients with a subcutaneous ICD
    Baalman, Sarah W. E.
    Mittal, Suneet
    Boersma, Lucas V. A.
    Perschbacher, Dave
    Brisben, Amy J.
    Mahajan, Deepa
    Groot, Joris R.
    Knops, Reinoud E.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (12): : 1467 - 1475
  • [34] Ischaemic stroke and bleeding rates in 'real-world' atrial fibrillation patients
    Ogilvie, Isla M.
    Welner, Sharon A.
    Cowell, Warren
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (01) : 34 - 44
  • [35] Real-world variability in dabigatran levels in patients with atrial fibrillation: comment
    Douxfils, J.
    Chatelain, B.
    Dogne, J. -M.
    Mullier, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (06) : 1166 - 1168
  • [36] Real-world variability in dabigatran levels in patients with atrial fibrillation: reply
    Chan, N. C.
    Hirsh, J.
    Ginsberg, J. S.
    Eikelboom, J. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (06) : 1168 - 1169
  • [37] Real-world evidence on short- and long-term outcomes for acute coronary syndrome patients with a prior history of atrial fibrillation
    Gouda, P.
    Savu, A.
    Bainey, K.
    Welsh, R.
    Sandhu, R. K.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1662 - 1662
  • [38] Incidence of Acute Coronary Syndrome in the General Medicare Population, 1992-2009: A Real-World Perspective
    Shroff, Gautam R.
    Heubner, Brooke M.
    Schein, Jeff
    Crivera, Concetta
    Herzog, Charles A.
    CIRCULATION, 2012, 126 (21)
  • [39] Dabigatran versus Warfarin Among Patients with Atrial Fibrillation: Real-World Post-Market Results
    Thelus, Rosenie
    Villines, Todd C.
    Coster, Trinka S.
    CIRCULATION, 2012, 126 (21)
  • [40] PRECISION COST-EFFECTIVENESS ANALYSIS OF RADIOFREQUENCY CATHETER ABLATION IN A REAL-WORLD ATRIAL FIBRILLATION POPULATION
    Sun, N.
    Chen, Y.
    Xie, X.
    Gao, L.
    Xie, G.
    Dong, P.
    VALUE IN HEALTH, 2017, 20 (09) : A614 - A614
12345